Skip to content

Individual reevaluation therapy Primairy Cardiovascular Prevention

Individual reevaluation therapy Primairy Cardiovascular Prevention - reevaluation therapy Primairy Cardiovascular Prevention

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON32052
Enrollment
300
Registered
2008-03-14
Start date
2008-05-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

therapy to prevent cardiovascular disease

Interventions

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: patients of 18 years and older who have used medication to lower the blood pressure or to lower cholesterol in the past 12 months and who are not known to have cardiovascular disease

Exclusion criteria

Exclusion criteria: serious cognitive impairment

Design outcomes

Primary

MeasureTime frame
Endpoints • Number and proportion of patients using medication for primary prevention of cardiovascular disease who are willing to participate in a reevaluation of the cardiovascular risk. • Number and proportion of patients who do not need preventive cardiovascular medication according to the new guidelines for cardiovascular risk management and who are willing to discontinue the medication.

Secondary

MeasureTime frame
The savings in yearly costs of medication duet o discontinuation of medication (total costs in euros for this medication of all patients in 2007 vs 2010, extrapolated on the basis of 3% index).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)